FdaApplication
ANDA 207873
Identifiers
- fda_app_no: ANDA207873
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2019-05-09 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MESALAMINE | MESALAMINE | 400MG | CAPSULE, DELAYED RELEASE;ORAL |
1 product